Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)

ClinicalTrials.gov ID: NCT02343445

Public ClinicalTrials.gov record NCT02343445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 2:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of the study is to evaluate the safety and tolerability of P-1037 and to determine whether the combination of P-1037 with hypertonic saline or P-1037 alone has a greater effect on lung function in patients with CF than placebo (0.17% saline).

Study identification

NCT ID
NCT02343445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Parion Sciences
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2015
Primary completion
Jan 31, 2016
Completion
Jan 31, 2016
Last update posted
Jul 25, 2021

2015 – 2016

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
Children's Hospital of Los Angeles Los Angeles California 90027
Univ of Florida Dept of Medicine Gainesville Florida 32610
University of Miami Adult CF Center Miami Florida 33136
Central Florida Pulmonary Group, PA Orlando Florida 32803
New Lung Associates Tampa Florida 33606
Chicago Cystic Fibrosis Institute Glenview Illinois 60025
University of Kansas Medical Center Kansas City Kansas 66160
Tulane University Health Sciences Center New Orleans Louisiana 70112
Maine Medical Center Portland Maine 04102
Johns Hopkins University Baltimore Maryland 21287
UMass Memorial medical Center Worcester Massachusetts 01655
Wayne State University/Harper University Hospital Detroit Michigan 48201
Washington University St Louis Missouri 63110
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Rutgets-Robert Wood Johnson Medical School New Brunswick New Jersey 08901
Pediatric Pulmonology/Cystic Fibrosis Somerville New Jersey 08876
Albany Medical College Albany New York 12208
Long Island Jewish Medical Center New Hyde Park New York 11042
University of North Carolina Chapel Hill North Carolina 27517
Clinical Research of Charlotte Charlotte North Carolina 28277
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Toledo Hospital Toledo Ohio 43606
Santiago Reyes Oklahoma City Oklahoma 73112
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224
Anderson Pharmaceutical Research Anderson South Carolina 29621
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 37232
Austin Children's Chest Associates Austin Texas 78723
UT Southwestern Medical Center Dallas Texas 75390
Alamo Clinical Research Associates San Antonio Texas 78212
Univ of Texas Health Science Center Tyler Texas 75708
University of Virginia Childrens Charlottesville Virginia 22908
University of Wisconsin UW Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02343445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2021 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02343445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →